PASCULLI, PATRIZIA
 Distribuzione geografica
Continente #
EU - Europa 511
NA - Nord America 403
AS - Asia 134
AF - Africa 9
SA - Sud America 3
Totale 1.060
Nazione #
US - Stati Uniti d'America 400
IT - Italia 343
SG - Singapore 76
SE - Svezia 75
IN - India 29
CN - Cina 21
BG - Bulgaria 19
FI - Finlandia 18
DE - Germania 17
FR - Francia 9
RO - Romania 8
GB - Regno Unito 7
TG - Togo 5
IE - Irlanda 4
JP - Giappone 4
MY - Malesia 3
BR - Brasile 2
CA - Canada 2
MK - Macedonia 2
SC - Seychelles 2
UA - Ucraina 2
AR - Argentina 1
BE - Belgio 1
BJ - Benin 1
CZ - Repubblica Ceca 1
GR - Grecia 1
MX - Messico 1
NL - Olanda 1
PL - Polonia 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 1.060
Città #
Rome 162
Chandler 70
Singapore 45
Ashburn 33
Fairfield 29
Milan 29
New York 22
Seattle 20
Sofia 19
San Paolo di Civitate 17
Woodbridge 15
Helsinki 13
Princeton 13
Houston 11
Lawrence 11
Millbury 11
Wilmington 11
Cambridge 10
Stockholm 10
Padova 9
Fremont 6
Vignola 6
Ann Arbor 5
Lappeenranta 5
Lomé 5
San Diego 5
Santa Clara 5
Beijing 4
Boardman 4
Boston 4
Dublin 4
Hyderabad 4
Naples 4
Paris 4
Porto Recanati 4
Andover 3
Chapel Hill 3
Dallas 3
Delhi 3
Hebei 3
Lidköping 3
London 3
Los Angeles 3
Mannheim 3
Norwalk 3
Shanghai 3
Araras 2
Bologna 2
Bonita Springs 2
Bühl 2
Fuzhou 2
Guangzhou 2
Mahé 2
Mori 2
Sabaudia 2
San Mateo 2
Tokyo 2
Toronto 2
Vercelli 2
Verona 2
Acton 1
Athens 1
Beograd 1
Bonndorf 1
Brno 1
Brussels 1
Colle Di Val D'elsa 1
Cotonou 1
Deiva Marina 1
Federal 1
Fonte Nuova 1
Fregene 1
Genova 1
Groningen 1
Grossostheim 1
Hangzhou 1
Iesi 1
Kilburn 1
Latina 1
Limeil-brévannes 1
Mexico City 1
Mountain View 1
Muizenberg 1
Mumbai 1
New Delhi 1
Nuremberg 1
Orsay 1
Redwood City 1
Reggio Emilia 1
Riyadh 1
Sacramento 1
San Jose 1
Saviano 1
Siena 1
Sovicille 1
Teramo 1
Thalmassing 1
Timișoara 1
Treviso 1
Vallefoglia 1
Totale 730
Nome #
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study 75
JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis 69
Major reduction of NKT cells in patients with severe COVID-19 pneumonia 69
Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia 67
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia. A retrospective cohort study 63
Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality 62
Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease 61
Modeling the contribution of male testosterone levels to the duration of positive COVID testing among hospitalized male COVID-19 patients 59
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia 57
Tocilizumab effects in COVID-19 pneumonia: role of CT texture analysis in quantitative assessment of response to therapy 47
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine 42
Neurofilament assessment in patients with cervical dystonia 37
Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection 35
Neuro-axonal damage and alteration of blood-brain barrier integrity in COVID-19 patients 33
Breakthrough infections after Covid-19 vaccinations do not elicit platelet hyper-activation and associate with high platelet-lymphocyte and low platelet-neutrophil aggregates 32
COVID-19 affects serum brain-derived neurotrophic factor and neurofilament light chain in aged men. Implications for morbidity and mortality 31
Blood biomarkers from the emergency department disclose severe omicron covid-19-associated outcomes 30
null 30
Quality of t-cell response to SARS-CoV-2 mrrna vaccine in art-treated plwh 28
COVID-19 Severity and androgen receptor polymorphism 28
Small fibre neuropathy frequently underlies the painful long-COVID syndrome 25
Immunogenicity and efficacy of vaccination in people living with human immunodeficiency virus 25
Biomarkers of neurological damag. From acute stage to post-acute sequelae of covid-19 25
Evaluation of BAFF, APRIL and CD40L in ocrelizumab-treated pwMS and infectious risk 24
Synergistic effect between SARS-CoV-2 wave and COVID-19 vaccination on the occurrence of mild symptoms in healthcare workers 22
Tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) and pulmonary involvement in COVID-19 pneumonia 22
Chest CT features of COVID-19 in vaccinated versus unvaccinated patients: use of CT severity score and outcome analysis 19
Male reproductive health after 3 months from SARS-CoV-2 infection. A multicentric study 14
Interplay between male testosterone levels and the risk for subsequent invasive respiratory assistance among COVID-19 patients at hospital admission 12
The impact of Cytomegalovirus infection on natural killer and CD8+ t cell phenotype in multiple sclerosis 11
Blood count and renal functionality assessments in the emergency section disclose morbidity and ortality in omicron COVID-19 patients: a retrospective study 6
null 3
Totale 1.163
Categoria #
all - tutte 5.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.385


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 0 0 0 3 6 3 2
2020/202191 2 10 0 7 0 13 0 7 6 14 17 15
2021/2022217 11 1 32 13 22 18 26 15 16 6 38 19
2022/2023304 29 55 37 29 30 28 9 28 18 4 28 9
2023/2024426 14 22 12 51 52 69 18 42 2 52 29 63
2024/2025111 37 43 31 0 0 0 0 0 0 0 0 0
Totale 1.163